therapy selection in brca-mutated ovarian cancer
Published 6 years ago • 203 plays • Length 2:45Download video MP4
Download video MP3
Similar videos
-
1:40
dr. moore on immunotherapy and parp combinations in brca-mutated ovarian cancer
-
4:17
case 2: olaparib in brca-mutated ovarian cancer
-
1:27
parp inhibition improves outcomes in patients with brca-mutated ovarian cancer
-
6:18
value of olaparib in brca-mutated advanced ovarian cancer
-
6:35
treatment options for patients with brca1/2
-
5:26
optimizing brca testing in advanced ovarian cancer
-
6:58
detecting somatic brca1/2 mutations in ovarian cancer
-
0:54
potential of genetic testing beyond brca1/2 in ovarian cancer
-
7:57
brca testing in ovarian cancer
-
1:21
dr. sessa on the management of brca1/2 mutations in ovarian cancer
-
3:59
universal screening for brca1 and brca2 mutations
-
3:29
rucaparib boosts pfs in brca-mutated recurrent ovarian cancer
-
7:00
brca testing for ovarian cancer
-
2:39
testing for brca and hrd in ovarian cancer
-
3:34
ovarian cancer: testing for brca mutations
-
1:34
dr. robert coleman on brca testing in ovarian cancer
-
2:00
dr. zakashansky on the benefit of maintenance olaparib in brca ovarian cancer
-
0:45
dr. leslie m. randall on early brca testing in ovarian cancer
-
1:17
dr. traina on parp inhibition in brca-mutated breast cancer